Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cell. 2013 Jan 17;152(1-2):340-51. doi: 10.1016/j.cell.2012.12.010.

Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.

Author information

  • 1Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7264, USA.

Abstract

Monitoring cancer and aging in vivo remains experimentally challenging. Here, we describe a luciferase knockin mouse (p16(LUC)), which faithfully reports expression of p16(INK4a), a tumor suppressor and aging biomarker. Lifelong assessment of luminescence in p16(+/LUC) mice revealed an exponential increase with aging, which was highly variable in a cohort of contemporaneously housed, syngeneic mice. Expression of p16(INK4a) with aging did not predict cancer development, suggesting that the accumulation of senescent cells is not a principal determinant of cancer-related death. In 14 of 14 tested tumor models, expression of p16(LUC) was focally activated by early neoplastic events, enabling visualization of tumors with sensitivity exceeding other imaging modalities. Activation of p16(INK4a) was noted in the emerging neoplasm and surrounding stromal cells. This work suggests that p16(INK4a) activation is a characteristic of all emerging cancers, making the p16(LUC) allele a sensitive, unbiased reporter of neoplastic transformation.

Copyright © 2013 Elsevier Inc. All rights reserved.

Comment in

  • Cancer cells report. [Nat Methods. 2013]
  • Senescence: Improved detection. [Nat Rev Cancer. 2013]
PMID:
23332765
[PubMed - indexed for MEDLINE]
PMCID:
PMC3718011
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk